68 related articles for article (PubMed ID: 23155270)
1. Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.
Piperis M; Provatopoulou X; Sagkriotis A; Kalogera E; Ampatzoglou E; Zografos GC; Athanasiou E; Gounaris A
Anticancer Res; 2012 Nov; 32(11):4993-5002. PubMed ID: 23155270
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.
Onitilo AA; Engel JM; Stankowski RV; Liang H; Berg RL; Doi SA
Breast Cancer Res Treat; 2012 Jul; 134(1):291-8. PubMed ID: 22476854
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
[TBL] [Abstract][Full Text] [Related]
4. Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study.
Shaffer R; Tyldesley S; Rolles M; Chia S; Mohamed I
Radiother Oncol; 2009 Jan; 90(1):122-6. PubMed ID: 18976826
[TBL] [Abstract][Full Text] [Related]
5. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
6. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
[TBL] [Abstract][Full Text] [Related]
7. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Gan WQ; Rousseau R;
Am J Respir Crit Care Med; 2008 Jun; 177(11):1207-14. PubMed ID: 18310480
[TBL] [Abstract][Full Text] [Related]
8. Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcome.
Bouwhuis MG; Collette S; Suciu S; de Groot ER; Kruit WH; Ten Hagen TL; Aarden LA; Eggermont AM; Swaak AJ;
Melanoma Res; 2011 Aug; 21(4):344-51. PubMed ID: 21546857
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
Arce-Salinas C; Lara-Medina FU; Alvarado-Miranda A; Castañeda-Soto N; Bargalló-Rocha E; Ramírez-Ugalde MT; Pérez-Sánchez V; Rivera L; Gambo-Vignole C; Santamaría-Galicia J; Nieves-Casas RI; Morán-Muñoz H; Mohar-Betancourt A
Rev Invest Clin; 2012; 64(1):9-16. PubMed ID: 22690524
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.
Malícková K; Kalousová M; Fucíková T; Bortlík M; Duricová D; Komárek V; Zima T; Janatková I; Lukás M
Scand J Clin Lab Invest; 2010 Jul; 70(4):294-9. PubMed ID: 20446880
[TBL] [Abstract][Full Text] [Related]
11. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.
Hill J; Heslop C; Man SF; Frohlich J; Connett JE; Anthonisen NR; Wise RA; Tashkin DP; Sin DD
Eur Heart J; 2011 Aug; 32(15):1918-25. PubMed ID: 21653561
[TBL] [Abstract][Full Text] [Related]
12. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb.
Gremmel T; Ay C; Seidinger D; Pabinger I; Panzer S; Koppensteiner R
J Vasc Surg; 2011 Dec; 54(6 Suppl):48S-55S. PubMed ID: 21890302
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.
Gopal P; Rutten EP; Dentener MA; Wouters EF; Reynaert NL
Eur J Clin Invest; 2012 Aug; 42(8):807-14. PubMed ID: 22288943
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era.
Palmieri C; Shah D; Krell J; Gojis O; Hogben K; Riddle P; Ahmad R; Tat T; Fox K; Porter A; Mahmoud S; Kirschke S; Shousha S; Gudi M; Coombes RC; Leonard R; Cleator S
Clin Breast Cancer; 2011 Apr; 11(2):93-102. PubMed ID: 21569995
[TBL] [Abstract][Full Text] [Related]
15. Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?
Beal K; Hudis C; Norton L; Wagman R; McCormick B
Breast J; 2005; 11(5):317-20. PubMed ID: 16174151
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients.
Rutqvist LE; Johansson H
Acta Oncol; 2006; 45(5):517-27. PubMed ID: 16864164
[TBL] [Abstract][Full Text] [Related]
17. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
19. [Sequential study of radiotherapy and hormonal therapy in breast cancer patients undergoing mastectomy or conservative surgery].
Wang XC; Huang XB; Zhang WD; Liu MZ; Guang XX; Liu XQ
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1964-9. PubMed ID: 19950570
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]